ID

36976

Beschreibung

Effects of Oral Sildenafil on Mortality in Adults With PAH; ODM derived from: https://clinicaltrials.gov/show/NCT02060487

Link

https://clinicaltrials.gov/show/NCT02060487

Stichworte

Versionen (1)
  1. 25.06.19 25.06.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

25. Juni 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Pulmonary Arterial Hypertension NCT02060487

Englisch

Eligibility Pulmonary Arterial Hypertension NCT02060487

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
subjects ≥ 18 <75 years of age with any of the following conditions:
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
idiopathic primary pulmonary arterial hypertension (ipah)
Beschreibung

Idiopathic pulmonary hypertension

Datentyp

boolean

Alias
UMLS CUI [1]
C0152171
pah secondary to connective tissue disease
Beschreibung

Pulmonary arterial hypertension Secondary to Connective Tissue Diseases

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2973725
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C0009782
pah with surgical repair (at least 5 years previously) of atrial septal defect (asd),ventricular septal defect (vsd), patent ductus arteriosus (pda) and aorto-pulmonary window
Beschreibung

Pulmonary arterial hypertension | Atrioseptoplasty | Ventricular Septal Defects | Patent ductus arteriosus | Aortopulmonary Septal Defect

Datentyp

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C0189965
UMLS CUI [3]
C0018818
UMLS CUI [4]
C0013274
UMLS CUI [5]
C0003516
pah diagnosis confirmed by right heart catheterization performed within 12 months prior to randomization
Beschreibung

Pulmonary arterial hypertension | Catheterization of right heart

Datentyp

boolean

Alias
UMLS CUI [1]
C2973725
UMLS CUI [2]
C0189896
functional class ii-iv; baseline 6mwd ≥ 50 m.
Beschreibung

Class Functional | 6-Minute Walk Test Distance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0456387
UMLS CUI [1,2]
C0205245
UMLS CUI [2,1]
C0430515
UMLS CUI [2,2]
C0429886
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
significant (ie, >2+) valvular disease other than tricuspid regurgitation or pulmonary regurgitation
Beschreibung

Valvular disease Stage | Exception Tricuspid Valve Insufficiency | Exception Pulmonary Valve Insufficiency

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3258293
UMLS CUI [1,2]
C1306673
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0040961
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0034088
history of cardiac arrest, respiratory arrest, hemodynamic collapse, cpr, ventricular tachycardia, ventricular fibrillation, or uncontrolled atrial fibrillation
Beschreibung

Cardiac Arrest | Respiratory arrest | Collapse Hemodynamic | Cardiopulmonary Resuscitation | Tachycardia, Ventricular | Ventricular Fibrillation | ATRIAL FIBRILLATION UNCONTROLLED

Datentyp

boolean

Alias
UMLS CUI [1]
C0018790
UMLS CUI [2]
C0162297
UMLS CUI [3,1]
C0344329
UMLS CUI [3,2]
C0019010
UMLS CUI [4]
C0007203
UMLS CUI [5]
C0042514
UMLS CUI [6]
C0042510
UMLS CUI [7]
C0741284
history of pulmonary embolism; history of chronic lung disease / restrictive lung disease (eg, chronic obstructive pulmonary disease (copd) or scleroderma) with impairment of lung function
Beschreibung

Pulmonary Embolism | Chronic lung disease | Restrictive lung disease | Chronic Obstructive Airway Disease | Scleroderma | Pulmonary function impairment

Datentyp

boolean

Alias
UMLS CUI [1]
C0034065
UMLS CUI [2]
C0746102
UMLS CUI [3]
C0085581
UMLS CUI [4]
C0024117
UMLS CUI [5]
C0011644
UMLS CUI [6]
C0858943
no prior long term treatment with pde-5 inhibitors
Beschreibung

Phosphodiesterase 5 inhibitor Long-term

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1318700
UMLS CUI [1,2]
C0443252
treatment with bosentan or riociguat within 3 months of randomization
Beschreibung

bosentan | riociguat

Datentyp

boolean

Alias
UMLS CUI [1]
C0252643
UMLS CUI [2]
C2717561
current treatment with nitrates or nitric oxide
Beschreibung

Nitrates | Nitric Oxide

Datentyp

boolean

Alias
UMLS CUI [1]
C0028125
UMLS CUI [2]
C0028128
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Pulmonary Arterial Hypertension NCT02060487

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
subjects ≥ 18 <75 years of age with any of the following conditions:
boolean
C0001779 (UMLS CUI [1])
Idiopathic pulmonary hypertension
Item
idiopathic primary pulmonary arterial hypertension (ipah)
boolean
C0152171 (UMLS CUI [1])
Pulmonary arterial hypertension Secondary to Connective Tissue Diseases
Item
pah secondary to connective tissue disease
boolean
C2973725 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0009782 (UMLS CUI [1,3])
Pulmonary arterial hypertension | Atrioseptoplasty | Ventricular Septal Defects | Patent ductus arteriosus | Aortopulmonary Septal Defect
Item
pah with surgical repair (at least 5 years previously) of atrial septal defect (asd),ventricular septal defect (vsd), patent ductus arteriosus (pda) and aorto-pulmonary window
boolean
C2973725 (UMLS CUI [1])
C0189965 (UMLS CUI [2])
C0018818 (UMLS CUI [3])
C0013274 (UMLS CUI [4])
C0003516 (UMLS CUI [5])
Pulmonary arterial hypertension | Catheterization of right heart
Item
pah diagnosis confirmed by right heart catheterization performed within 12 months prior to randomization
boolean
C2973725 (UMLS CUI [1])
C0189896 (UMLS CUI [2])
Class Functional | 6-Minute Walk Test Distance
Item
functional class ii-iv; baseline 6mwd ≥ 50 m.
boolean
C0456387 (UMLS CUI [1,1])
C0205245 (UMLS CUI [1,2])
C0430515 (UMLS CUI [2,1])
C0429886 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Valvular disease Stage | Exception Tricuspid Valve Insufficiency | Exception Pulmonary Valve Insufficiency
Item
significant (ie, >2+) valvular disease other than tricuspid regurgitation or pulmonary regurgitation
boolean
C3258293 (UMLS CUI [1,1])
C1306673 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0040961 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0034088 (UMLS CUI [3,2])
Cardiac Arrest | Respiratory arrest | Collapse Hemodynamic | Cardiopulmonary Resuscitation | Tachycardia, Ventricular | Ventricular Fibrillation | ATRIAL FIBRILLATION UNCONTROLLED
Item
history of cardiac arrest, respiratory arrest, hemodynamic collapse, cpr, ventricular tachycardia, ventricular fibrillation, or uncontrolled atrial fibrillation
boolean
C0018790 (UMLS CUI [1])
C0162297 (UMLS CUI [2])
C0344329 (UMLS CUI [3,1])
C0019010 (UMLS CUI [3,2])
C0007203 (UMLS CUI [4])
C0042514 (UMLS CUI [5])
C0042510 (UMLS CUI [6])
C0741284 (UMLS CUI [7])
Pulmonary Embolism | Chronic lung disease | Restrictive lung disease | Chronic Obstructive Airway Disease | Scleroderma | Pulmonary function impairment
Item
history of pulmonary embolism; history of chronic lung disease / restrictive lung disease (eg, chronic obstructive pulmonary disease (copd) or scleroderma) with impairment of lung function
boolean
C0034065 (UMLS CUI [1])
C0746102 (UMLS CUI [2])
C0085581 (UMLS CUI [3])
C0024117 (UMLS CUI [4])
C0011644 (UMLS CUI [5])
C0858943 (UMLS CUI [6])
Phosphodiesterase 5 inhibitor Long-term
Item
no prior long term treatment with pde-5 inhibitors
boolean
C1318700 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
bosentan | riociguat
Item
treatment with bosentan or riociguat within 3 months of randomization
boolean
C0252643 (UMLS CUI [1])
C2717561 (UMLS CUI [2])
Nitrates | Nitric Oxide
Item
current treatment with nitrates or nitric oxide
boolean
C0028125 (UMLS CUI [1])
C0028128 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video